SCHEMBL23558461

SCHEMBL23558461

CCC1(CC)CC(=O)c2cc(-c3cc(-c4ccccc4)no3)ccc2O1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 6/20 0.45
▸ RAB9A P51151 6/20 0.45
▸ CASP3 P42574 1/20 0.45
▸ SENP8 Q96LD8 1/20 0.45
▸ SENP7 Q9BQF6 1/20 0.45
▸ SENP6 Q9GZR1 1/20 0.45
▸ PTGS2 P35354 2/20 0.44
▸ ABCB1 P08183 1/20 0.41
▸ ABCC1 P33527 1/20 0.41
▸ MMP13 P45452 1/20 0.41
▸ CXCR1 P25024 6/20 0.41
▸ CNR1 P21554 1/20 0.40
▸ CNR2 P34972 1/20 0.40
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ CYP2C9 P11712 2/20 0.39
▸ CYP2C19 P33261 2/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ NFKB1 P19838 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25856900 0.90 MAOB (0.43) NPC1RAB9ACASP3SENP8SENP7
SCHEMBL25856949 0.89 CNR1 (0.41) NPC1RAB9ACASP3SENP8SENP7
SCHEMBL25856856 0.89 NPC1 (0.43) NPC1RAB9ACASP3SENP8SENP7
SCHEMBL25856895 0.88 RAB9A (0.42) NPC1RAB9AABCB1ABCC1CXCR1
SCHEMBL23558238 0.87 ALDH1A1 (0.45) NPC1RAB9ACXCR1MEN1KMT2A
SCHEMBL25863238 0.87 CXCR1 (0.40) NPC1RAB9AABCB1ABCC1MMP13
SCHEMBL23558404 0.86 ABCB1 (0.51) NPC1RAB9ACASP3SENP8SENP7
SCHEMBL23558330 0.83 RAB9A (0.40) NPC1RAB9AABCB1ABCC1CXCR1
SCHEMBL25863749 0.83 ABCB1 (0.35) ABCB1ABCC1CNR1CNR2
SCHEMBL23558395 0.82 ABCB1 (0.38) NPC1RAB9AABCB1ABCC1CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210188826-A1 COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME TREVENA, INC. 2021-06-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210188826-A1 COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME S1PR1, S1PR2, S1PR3 NPC1 301/4885RAB9A 3056/4885CASP3 3079/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback